Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Annual Report 2002 - Essential Drugs and Medicines Policy: Supporting Countries to Close the Access Gap
(2003; 20 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentDeveloping a monitoring culture to improve impact
View the documentTraditional and complementary medicine: putting policy into action
View the documentKey country support in Africa and Eastern Mediterranean
View the documentWHO Collaborating Centres: supplying active support for medicines work
View the documentHow is TRIPS affecting access to medicines?
View the documentDevelopment of the essential drugs concept over the past 25 years
View the documentMeasuring access to antimalarials
View the documentStrengthening regional and national bulk procurement
View the documentLearning from successful supply systems
View the documentWorking out the cost of medicines
View the documentSupporting MDG target on access to essential medicines
View the documentCommon guideline for evaluating new medicines in Baltic countries
View the documentNGO toolkit for improving access to HIV/AIDS treatment
View the documentHarmonizing medicines regulation in the Americas
View the documentGood manufacturing practice in China: rapid progress
View the documentPharmacovigilance: detecting and reporting adverse drug reactions
View the documentVariations in prescribing information in 26 countries
View the document10th ICDRA: an international basis for medicines regulation
View the documentFighting poor-quality drugs
View the documentImproving medicines use in hospitals in Cambodia and Lao PDR
View the documentWHO-India Essential Drugs Programme: multiplying impact
View the documentOman: improving antibiotic use in primary health care

WHO-India Essential Drugs Programme: multiplying impact

WHO expanded its support to the WHO-India Essential Drugs Programme in 1997. This was to enable the Programme to extend the success of its Delhi Capital Territory Essential Medicines Programme, largely implemented by the Delhi Society for Promotion of Rational Use of Drugs (DSPRUD). DSPRUD's activities during 1997- 2002 were externally evaluated in October 2002.

The hallmark of DSPRUD activities has been close cooperation with the Delhi State Government. DSPRUD has also assisted nongovernmental organizations (NGOs) in other states, such as Rajasthan, and large institutions such as the Municipal Corporation of Mumbai, with activities to promote rational use of medicines. The evaluation found that DSPRUD's design and implementation of a transparent pooled procurement and distribution system had resulted in a consistent supply of good-quality essential medicines for Delhi State's public health facilities. It also noted that execution of the programme through an NGO had minimized bureaucracy and encouraged flexibility for developing linkages with medical schools, universities and other institutions.

By the end of 2001, the WHO-India Essential Drugs Programme was operating comprehensive essential drugs programmes in 6 states and partial programmes in a further 8 states. In 2002, partial programmes were introduced in Bihar, Chattisgarh, Kerala, Orissa and Uttar Pradesh, and significant progress made in developing standard treatment guidelines (STGs). STGs were developed as follows:

Delhi State: STGs were prepared by DSPRUD, for treating patients with specific clinical conditions, following an extensive consultative process involving 70 clinicians, from all levels of health care, and including some private practitioners.

Karnataka State: STGs for primary health care facilities were prepared and distributed to district health officers.

Madya Pradesh State: STGs were developed for reproductive and child health.

Maharashtra State: STGs for treating in-patients of secondary and tertiary health-care facilities in the Municipal Corporation of Greater Mumbai were prepared and published by the Department of Clinical Pharmacology, BYL Nair Charitable Hospital.

Uttar Pradesh State: STGs were prepared with technical support from DSPRUD and will be distributed by the Government of Uttar Pradesh to doctors in hospitals and primary health centres.


to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017